Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA

Molecular Therapy

Volumn 15, Issue 3, 2007, Pages 534-541

  Weinberg, Marc S ^a   Ely, Abdullah ^a   Barichievy, Samantha ^a   Crowther, Carol ^a   Mufamadi, Steven ^a   Carmona, Sergio ^a   Arbuthnot, Patrick ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DICER; HEPATITIS B VIRUS X PROTEIN; INTERFERON; LONG HAIRPIN RNA; PLASMID VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASE PAIRING; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME SUBSTRATE; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; GENETIC CODE; GENETIC CONSERVATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; RNA SYNTHESIS; RNA VECTOR; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; CELL LINE; GENE EXPRESSION; HEPATITIS B VIRUS; HUMANS; INTERFERONS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; RNA INTERFERENCE; VIRUS REPLICATION;

HEPATITIS B VIRUS; MURINAE;

EID: 33847195409     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300077     Document Type: Article

References (43)

1. Hanazaki, K (2004). Antiviral therapy for chronic hepatitis B: A review. Curr Drug Targets Inflamm Allergy 3: 63-70.
2. van Nunen, AB, Janssen, HL, Wolters, LM, Niesters, HG, de Man, RA and Schalm, SW (2001). Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug? Antiviral Res 52: 139-146.
3. Carmona, S, Ely, A, Crowther, C, Moolla, N, Salazar, FH and Marion, PL et al. (2006). Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol Ther 13: 411-421.
4. McCaffrey, AP, Nakai, H, Pandey, K, Huang, Z, Salazar, FH and Xu, H et al. (2003). Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 21: 639-644.
5. Uprichard, SL, Boyd, B, Althage, A and Chisari, FV (2005). Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc Natl Acad Sci USA 102: 773-778.
6. Giladi, H, Ketzinel-Gilad, M, Rivkin, L, Felig, Y, Nussbaum, O and Galun, E (2003). Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 8: 769-776.
7. Klein, C, Bock CT, Wedemeyer, H, Wustefeld, T, Locarnini, S and Dienes, HP et al. (2003). Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and sIRNA. Gastroenterology 125: 9-18.
8. Shlomai, A and Shaul, Y (2003). Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37: 764-770.
9. Provost, P, Dishart, D, Doucet, J, Frendewey, D, Samuelsson, B and Radmark, O (2002). Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J 21: 5864-5874.
10. Zhang, H, Kolb, FA, Brondani, V, Billy, E and Filipowicz, W (2002). Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J 21: 5875-5885.
11. Rand, TA, Petersen, S, Du, F and Wang, X (2005). Argonaute2 cleaves the antiguide strand of siRNA during RISC activation. Cell 123: 621-629.
12. Brummelkamp, TR, Bernards, R and Agami, R (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
13. Elbashir, SM, Harborth, J, Lendeckel, W, Yalcin, A, Weber, K and Tuschl, T (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
14. Elbashir, SM, Lendeckel, W and Tuschl, T (2001). RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15: 188-200.
15. Miyagishi, M and Taira, K (2002). U6 promoter driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20: 497-500.
16. Haasnoot, PC, Cupac, D and Berkhout, B (2003). Inhibition of virus replication by RNA interference. J Biomed Sci 10: 607-616.
17. Saleh, MC, Van Rij, RP and Andino, R (2004). RNA silencing in viral infections: Insights from poliovirus. Virus Res 102: 11-17.
18. Gitlin, L, Stone, JK and Andino, R (2005). Poliovirus escape from RNA interference: Short interfering RNA-target recognition and implications for therapeutic approaches. J Virol 79: 1027-1035.
19. Boden, D, Pusch, O, Lee, F, Tucker, L and Ramratnam, B (2003). Human immunodeficiency virus type 1 escape from RNA interference. J Virol 77: 11531-11535.
20. Das, AT, Brummelkamp, TR, Westerhout, EM, Vink, M, Madiredjo, M and Bernards, R et al. (2004). Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 78: 2601-2605.
21. Wilson, JA and Richardson, CD (2005). Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J Virol 79: 7050-7058.
22. Stark, GR, Kerr, IM, Williams, BR, Silverman, RH and Schreiber, RD (1998). How cells respond to interferons. Annu Rev Biochem 67: 227-264.
23. Robbins, MA, Li, M, Leung, I, Li, H, Boyer, DV and Song, Y et al. (2006). Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro. Nat Biotechnol 24: 566-571.
24. Akashi, H, Miyagishi, M, Yokota, T, Watanabe, T, Hino, T and Nishina, K et al. (2005). Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA. Mol BioSyst 1: 382-390.
25. Watanabe, T, Sudoh, M, Miyagishi, M, Akashi, H, Arai, M and Inoue, K et al. (2006). Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype. Gene Ther 13: 883-892.
26. Kimbi, GC, Kramvis, A and Kew, MC (2004). Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa. J Gen Virol 85: 1211-1220.
27. Nassal, M (1992). The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 66: 4107-4116.
28. Passman, M, Weinberg, M, Kew, M and Arbuthnot, P (2000). In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells. Biochem Biophys Res Commun 268: 728-733.
29. Weinberg, M, Passman, M, Kew, M and Arbuthnot, P (2000). Hammerhead ribozyme-mediated inhibition of hepatitis B virus X gene expression in cultured cells. J Hepatol 33: 142-151.
30. Li, K, Chen, Z, Kato, N, Gale, M Jr and Lemon, SM (2005). Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem 280: 16739-16747.
31. Pei, Y and Tuschl, T (2006). On the art of identifying effective and specific siRNAs. Nat Methods 3: 670-676.
32. Myers, JW and Ferrell, JE (2005). Silencing gene expression with Dicer-generated siRNA pools. Methods Mol Biol 309: 93-196.
33. Myers, JW, Jones, JT, Meyer, T and Ferrell, JE Jr (2003). Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing. Nat Biotechnol 21: 324-328.
34. Strat, A, Gao, L, Utsuki, T, Cheng, B, Nuthalapaty, S and Mathis, JM et al. (2006). Specific and nontoxic silencing in mammalian cells with expressed long dsRNAs. Nucleic Acids Res 34: 3803-3810.
35. Caplen, NJ, Parrish, S, Imani, F, Fire, A and Morgan, RA (2001). Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 98: 9742-9747.
36. Kim, DH, Longo, M, Han, Y, Lundberg, P, Cantin, E and Rossi, JJ (2004). Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 22: 321-325.
37. Judge, AD, Sood, V, Shaw, JR, Fang, D, McClintock, K and MacLachlan, I (2005). Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 23: 457-462.
38. Marques, JT, Devosse, T, Wang, D, Zamanian-Daryoush, M, Serbinowski, P and Hartmann, R et al. (2006). A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 24: 559-565.
39. Cullen, BR (2006). Enhancing and confirming the specificity of RNAi experiments. Nat Methods 3: 677-681.
40. Grimm, D, Streetz, KL, Jopling, CL, Storm, TA, Pandey, K and Davis, CR et al. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441: 537-541.
41. Castanotto, D, Li, H and Rossi, JJ (2002). Functional siRNA expression from transfected PCR products. RNA 8: 1454-1460.
42. Heermann, KH, Gerlich, WH, Chudy, M, Schaefer, S and Thomssen, R (1999). Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol 37: 68-73.
43. Song, E, Zhu, P, Lee, SK, Chowdhury, D, Kussman, S and Dykxhoorn, DM et al. (2005). Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 23: 709-717.